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EDITORIAL
Dahl's hypothesis that a saluretic substance may be
responsible for a sustained rise in arterial pressure: Its
possible role in essential hypertension
In 1969, Dahi, Knudsen, and Iwai [1] were the
first to propose that a circulating saluretic substance
might cause a sustained rise in arterial pressure in
salt-sensitive hypertensive rats. Haddy and Over-
beck [2], in 1976, extended this hypothesis to in-
clude the rise in blood pressure that occurs with
volume expansion, including primary aldosteron-
ism, cortisone administration, chronic renal failure,
and some forms of experimental hypertension.
Recently, Blaustein [3] described how a rise in
the concentration of a circulating inhibitor of so-
dium transport might cause a rise in arterial pres-
sure. Blaustein's hypothesis and the increasing evi-
dence on the nature of hypertension in animals and
man, and of the nature of natriuretic hormone [4],
enable us to use Dahi's original hypothesis [1], and
Borst and Borst de Geus's [5] main tenet, that the
kidney's control of sodium excretion is paramount
in the control of blood pressure, to form a possible
explanation for the origins of essential hyper-
tension. The following account outlines the relevant
animal work and then describes parallel observa-
tions that have been made in man.
Rat studies
In rats, hypertension of an unknown cause is
known as spontaneous hypertension. Its incidence
in rat colonies varies from 11 to 55% [6, 7], and it is
related linearly to age and to the amount of sodium
in the diet [8]. Dahi [9] noted, however, that some
rats on a high intake of salt did not develop hyper-
tension. By selective in-breeding of young rats on a
high-sodium diet, his group was able to show that
this difference was determined genetically. They
developed one strain, known as "sodium sensi-
tive," that develops hypertension on a high-sodium
intake, and another, known as "salt resistant," that
does not [10, 11]. Others also have demonstrated
that hypertension in rats is determined genetically
by selective in-breeding from rats that develop hy-
pertension on a normal-sodium diet (the spontane-
ously hypertensive rat") and from those that do not
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(the "normotensive rat") [7, 12, 13]. It is interesting
that Dahi's salt-sensitive strain was developed in
three generations [10], whereas it took 18 genera-
tions to breed the spontaneously hypertensive
strain [7].
Tobian et al [14] were the first to show that the
genetic fault that causes hypertension in the so-
dium-sensitive strain resides in the kidney. This
work was confirmed by Dahl, Heine, and Thomp-
son [15, 16]. Renal transplants were performed in 6-
week-old normotensive rats. When the kidney from
a normotensive sodium-sensitive donor rat was
placed into a normotensive sodium-resistant recipi-
ent rat, the sodium-resistant recipient developed
hypertension. Other experiments were performed
when the sodium-sensitive rats had been hyperten-
sive for about 3 weeks [17]. The insertion of a kid-
ney from a normotensive sodium-resistant rat low-
ered the blood pressure of the sodium-sensitive rat
even though a high intake of sodium was continued.
Bianchi et al [18, 19] and Fox and Bianchi [20] have
performed similar cross-transplantation experi-
ments in spontaneously hypertensive rats and ob-
tained similar results. They also confirmed that the
hypertension followed" the kidney even when the
kidney was taken from a young donor, from the
spontaneously hypertensive strain, before the onset
of hypertension.
The functional renal abnormality that is respon-
sible for the rise in blood pressure in both hyperten-
sive strains of rats appears to be a difficulty in their
ability to eliminate sodium. In the sodium-sensitive
strain, the hypertension is dependent on a high-so-
dium intake [9], and, in addition, isolated perfused
kidneys from normotensive donors of the salt-sensi-
tive strain excrete less sodium than do the kidneys
of the sodium-resistant strain [21]. In the spontane-
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ously hypertensive strain, the onset of hypertension
occurs during a period of positive sodium balance
[22-24] between the 25th and 52nd day of age. In the
adult spontaneously hypertensive rat, the difficulty
in eliminating sodium may be related to Bianchi and
Baer's [25] finding that the kidney contains fewer
glomeruli and has a lower single nephron filtration
rate [26]. It follows that in each hypertensive strain
of rat there should be a tendency for an increase in
extracellular fluid volume. This can be demon-
strated in the spontaneously hypertensive strain at
the time the pressure is rising, but thereafter the in-
crease is no longer significant [22]. Nevertheless,
the probability that the hypertensive strains prob-
ably have a slight corrected increase in extracellular
fluid volume is supported by the response of both
strains to an acute i.v. saline load [23, 27]. In both,
the rise in urinary sodium excretion is more rapid
than that of the normotensive sodium-resistant
rat or of the normotensive rat. Such an exaggerated
natriuresis is known to accompany a persistent
state of corrected volume expansion (see later). It is
important to note that, in these two strains of hype r-
tensive rats, the accelerated natriuresis can be
demonstrated even when the animal is young before
the blood pressure has risen [23, 27]. This is in line
with the observation that an accelerated natriuresis
in hypertensive animals is not related to changes in
hydrostatic or colloid osmotic pressures in the renal
cortical arterial microvasculature [28]. The low
plasma renin activity that is found persistently in
the salt-sensitive hypertensive rat [29] also suggests
that in this strain there is a continuous process of
correction of a slightly expanded extracellular fluid
volume. In the spontaneously hypertensive rat,
plasma renin falls during the period when the pres-
sure is rising, which is coincident with the period of
sodium retention. This suggests that in this strain
there is, at this time, a period of extracellular fluid
volume expansion, though it is not possible to de-
tect any measureable increase [22]. Thereafter, the
plasma renin returns to normal.
Dahl et al [30] and Knudsen et al [31] investigated
the mechanism whereby a difficulty in eliminating
sodium might cause hypertension. They used the
technique of parabiosis [32], in which two animals
are chronically united by an area of skin and sub-
cutaneous tissues. Parabiosis of a member of the so-
dium-sensitive strain with a member of the sodium-
resistant strain considerably modified the expected
response to a high-sodium intake. The sodium-re-
sitant rat rapidly became hypertensive, whereas in
the sodium-sensitive rat, the rate of development of
hypertension, the average level of hypertension,
and the final blood pressure achieved were all con-
siderably reduced. These results led Knudsen et al
[31] to suggest that the hypertension was possibly
due to a "saluretic" substance that also had the
capacity to raise the blood pressure. Attempts to
reproduce these observations in the spontaneously
hypertensive rat, however, have not been success-
ful [33].
Dahl's proposal that, in the rat, an inherited diffi-
culty in excreting sodium might lead to a com-
pensatory rise in the circulating concentration of a
saluretic substance, which, while returning sodium
balance towards normal, might also cause hyper-
tension, is now more tenable than when it was first
proposed. Increased concentrations of natriuretic
substances that are sodium-transport inhibitors
have been demonstrated in blood and urine in both
man and animals during a high intake of sodium,
and after acute volume expansion [4, 34-36]. There
are at least two natriuretic substances. One has a
molecular weight of less than 500 daltons and is
short acting [37]. The other has a molecular weight
possibly greater than 10,000 daltons and is slow act-
ing [38]. Most studies have been made on the small
molecular weight substance, but they have not been
performed to investigate the etiology of hyper-
tension. There is one observation [39], however,
that the amount of the large-molecular-weight na-
triuretic substance is greater in the urine of pa-
tients with essential hypertension after they have
received an acute i.v. saline load than it is in the
urine of normotensive subjects subjected to the
same stimulus. These natriuretic substances are of-
ten referred to as natriuretic hormones. Intravenous
injections of extracts containing these substances,
however, cause a transient natriuresis without an
accompanying rise in blood pressure. Therefore, as
Haddy and Overbeck [2] have pointed out, if a
raised concentration of these substances in the
blood is responsible for hypertension in states of
unequivocal volume expansion, then the rise in
pressure must be due to their prolonged action.
There is both direct and indirect evidence that a
circulating substance is responsible for the rise in
blood pressure in the two strains of hypertensive
rat. The injection of serum from salt-sensitive hy-
pertensive rats into specifically prepared bioassay
rats increases their pressor response to infused
noradrenaline [40]. Also, Tobian et al [41] have
found that the blood of the salt-sensitive hyperten-
sive rat causes a significant increase in the vascular
resistance of the cross-perfused hindquarters of the
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normotensive salt-resistant rat. It is possible, there-
fore, that the increased vascular sensitivity of both
the salt-sensitive [42] and the spontaneously hyper-
tensive strain of rats [43—45] to vasoconstrictive
substances is due to a change in the concentration
of a circulating substance. The results of experi-
ments on isolated strips of arterial wall [46-48] sug-
gest that the arteries from spontaneously hyperten-
sive rats are abnormal. Femoral arterial strips [48]
have an increased number of rhythmic spontaneous
contractions, and both femoral arterial and aortic
strips [47, 48] have an increased strength of con-
traction when the bath, potassium, lanthanum, and
strontium is increased, which suggests that the
cell membrane of the vascular smooth muscle of
the hypertensive rat is more labile than that in the
normal rat" [48]. The response of arterial strips to
norepinephrine is less consistent. Some workers
find an increased contraction [46] or a continuing
response at very low concentrations [48]. Shibata
and Kurahashi [47], however, have found that the
contractile response of aortic strips from spontane-
ously hypertensive rats is significantly less than is
the response of strips from normotensive rats. The
latter is consistent with the early observations of
Spector et a! [49] and Haeusler and Haefaly [50],
who found that the vasculature of their spontane-
ously hypertensive rats were less responsive to nor-
epinephrine than was the vasculature of the normo-
tensive rat. Two of the observations that demon-
strate increased vascular sensitivity were made in
young animals before the onset of hypertension [42,
43], and three observations that demonstrate that
the cell membrane of the vascular smooth muscle is
abnormal were made in vitro on strips of arterial
wall [46—48]. This suggests that the observed
changes in vascular reactivity may not be due sim-
ply to hypertensive structural changes [51].
Dahi's further proposal that the circulating sub-
stance might be "saluretic," if it is interpreted in a
wider sense of inhibiting sodium transport, has been
considerably strengthened by an increasing number
of in vitro observations that the arterial smooth
muscle of spontaneously hypertensive rats and the
red cells of both salt-sensitive and spontaneously
hypertensive rats have an abnormality of sodium,
potassium, and calcium transport. Aortic muscle
from the spontaneously hypertensive rat has a de-
creased ability to accumulate intracellular potas-
sium, an excess of intracellular sodium, and an in-
crease in the turnover of potassium and chloride
[52]. Others have found also a diminished sodium
efflux, a raised intracellular sodium content, and an
impaired calcium transport in the arteries of the so-
dium-sensitive [53] and the spontaneously hyper-
tensive rat [54-56]. Abnormalities of sodium and
potassium transport have been found in red cells
from both the salt-sensitive [57] and the spontane-
ously hypertensive rat [58, 59]. Techniques differ,
but the interpretation that has been placed on the
results is that the abnormalities are due to an in-
creased permeability of the cell membrane [58—60].
Some of these observations were made in animals
before they had developed hypertension [58]. Post-
nov, Orlov, and Pokudin have also demonstrated that
red cell membranes have a decreased calcium-bind-
ing capacity, which they consider may be associated
with an increase in permeability [60]. In addition,
Postnov and Reznikova have found that the adipose
tissue of spontaneously hypertensive rats also show
an alteration of cell membrane function [61].
To complete Dahi's hypothesis [1], Blaustein [3]
summarized the existing data, which he suggests
may explain how an abnormality of sodium and po-
tassium transport in arteriolar smooth muscle might
cause an increase in vascular reactivity and hyper-
tension. The tension of arteriolar smooth muscle is
determined by the intracellular calcium concentra-
tion. An increase in concentration increases the ten-
sion [62, 63]. Recently, it has been shown that, in
addition to the more familiar sodium and potassium
pump on the cell membrane, there is another mech-
anism that is responsible for the movement of cal-
cium out of the cell in exchange for sodium [64].
The activity of this sodium-calcium mechanism is
influenced by the intracellular sodium concentra-
tion, so that a rise in concentration inhibits the ex-
change. It follows that an impairment in the net ef-
fect of the main sodium-potassium pump sufficient
to cause a rise in intracellular sodium concentration
in the smooth muscle will depress the sodium-cal-
cium exchange, increase the intracellular calcium
concentration, and thus increase the tension of the
muscle. This is the probable explanation for the rise
in vascular resistance and blood pressure, which
occurs on giving therapeutic doses of sodium-trans-
port-inhibiting cardiac glycosides to man [65].
Blaustein [3] has calculated that the sensitivity of
this system may be such that a rise of 0.5 mmoles/
liter in intracellular sodium concentration may give
rise to an average increase of intracellular calcium
concentration of 4 to 40 /Lmoles/liter, which would
increase the resting tone of vascular smooth muscle
by approximately 50%.
In both hypertensive strains of rat, therefore,
there is a chain of evidence that suggests that the
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rise in blood pressure may be due to a genetic diffi-
culty in excreting sodium because of an abnormality
of the kidney. And that the consequential rise in ex-
tracellular fluid volume stimulates an increase in the
concentration of a circulating sodium-transport-in-
hibitor, which increases sodium excretion and thus
prevents further retention of sodium. At the same
tine, this substance causes a widespread inhibition
of sodium-potassium transport, which, in the arter-
ies, results in vasoconstriction and hypertension.
Fluinan studies
In man, hypertension of an unknown cause is
known as essential hypertension. For obvious rea-
sons, some of the experiments performed in rats
have not been repeated in man. Nevertheless, the
similarities that can be drawn between the hyper-
tension in stock colony rats, the two inbred strains
of hypertensive rats, and essential hypertension in
man are so close as to suggest that their underlying
etiology may be the same.
As in the rat, the hereditary nature of essential
hypertension in man is well-documented 166]. Simi-
larly, as in the rat, there is increasing evidence that
in man essential hypertension is related to sodium
metabolism 167]. There are numerous reports relat-
ing sodium intake to the prevalence of hyper-
tension. When the daily dietary ingestion of sodium
is below approximately 60 mmoles, as in unaccul-
turated peoples [67-69], the prevalence of hyper-
tension is negligible. Whereas when the daily intake
is over 400 mmoles, as in the North Island of Japan,
the prevalence of hypertension is approximately
40% [70-72]. The prevalence of hypertension in
populations with a daily sodium ingestion between 60
and 400 mmoles lies between that found at these
two extremes [67, 73]. The observations made in
Framingham illustrate this relation particularly well
[74]. The correlation between sodium intake and
prevalence of hypertension is unlikely to be due to
racial differences, for it can be demonstrated within
a race when the sodium intake of the varying geo-
graphic districts within which the race lives also dif-
fers [72]. One dissenting voice against the propo-
sition that in man the prevalence of hypertension
in various geographic groups is related to the aver-
age sodium ingestion was that of Schroeder in 1958
[75]. He was particularly critical in that he had not
been able to find any reports of measurements of
urinary sodium excretion to substantiate the claim
that in Japan the prevalence of hypertension is re-
lated to sodium intake. He was hampered in that
much of his information was from personal commu-
nications and by not having been told that in the
preceding 4 years the data he was seeking had been
published by Fukuda [70] and Takamatsu [71].
These workers had each described the high preva-
lence of hypertension and had confirmed with uri-
nary sodium chloride measurements that the report-
ed calculated high ingestions of sodium chloride in
the northern districts in Japan were true, with an
average daily urinary sodium excretions of about
460 mmoles, and a maximum of 850 and 1000
mmoles. These findings were later confirmed by Sa-
saki 172]. Overall, therefore, it appears that the geo-
graphic prevalence of hypertension in man is re-
lated to the dietary intake of sodium. This relation-
ship is startlingly similar to that found by Meneely
et a! [8, 9] in stock colony rats fed varying quantities
of salt.
Other workers [76, 77], however, have pointed
out that there is no correlation within a group be-
tween the prevalence of hypertension and the inges-
tion of sodium, and that therefore sodium intake is
not an important etiologic factor. Such a contention
presupposes that those individuals who are liable to
develop hypertension all have an equal tendency to
do so. It is true that this appears to be almost true
when it is artificially engendered in the rat by in-
breeding specifically for hypertension. But man's
customary out-breeding ensures that such a genetic
homogeneity does not occur. If it is accepted that in
man the genetic tendency to develop hypertension
is greater in some individuals than in others, as it is
in a stock colony of rats, then though the preva-
lence of hypertension in the group will rise as the
average salt intake rises, there does not need to be
any correlation between the intake of sodium and
the development of hypertension within the group.
Another objection against comparing the rate of de-
velopment of hypertension in man and the rat is that
in man both the arterial pressure and the prevalence
of hypertension rise gradually with age [66, 76],
whereas in the two artificial models of in-bred hy-
pertensive rats, both the pressure and the preva-
lence are maximal early in life. In a stock colony of
rats, however, which have not been specifically
bred for hypertension, and which, in this respect,
are more like the human race than the two in-bred
hypertensive strains of rats, the rise in arterial pres-
sure and the prevalence of hypertension both rise
gradually with age [6, 7], as they do in man.
In man with established essential hypertension,
evidence that there is an expanded extracellular
fluid space is as difficult to detect as it is in the hy-
pertensive rat, once hypertension has developed.
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The evidence is circumstantial. As in some of the
hypertensive rats, a proportion of hypertensive pa-
tients have a low plasma renin activity 178]; And, as
in the hypertensive rats, patients with essential hy-
pertension also have an accelerated natriuresis
when given an i.v. saline load [79, 80]. As expected,
the natriuresis is greatest in hypertensive patients
with a low plasma renin activity [81]. The acceler-
ated natriuresis not only occurs when the hyper-
tension is established but, as in the rat, is also de-
monstrable before the blood pressure has risen, for
it can be demonstrated in the normotensive sons of
hypertensive fathers [82]. And, as in the rat, the ac-
celerated natriuresis in patients with essential hy-
pertension is not related to changes in colloid os-
motic or hydrostatic pressures in the kidney [83].
An accelerated natriuresis is suggestive of a state
of continuing correction of extracellular fluid ex-
pansion, for patients with primary hyperaldostero-
nism [84], or normal subjects given aldosterone [85],
most of whom, but not all, have a slight demon-
strable expansion of extracellular volume (also all
have an accelerated natriuresis when given saline).
Such patients also demonstrate a reversed diurnal
rhythm for sodium [86]. Patients with essential hy-
pertension also have reversed diurnal rhythm [87], a
finding that can also be demonstrated in the normo-
tensive children of hypertensive parents (Parfrey
PS, personal communication). This phenomenon is
additional evidence that suggests that essential hy-
pertension is associated with a state of continuous
correction of a slightly expanded extracellular fluid
volume expansion. Bianchi et al's findings [88] that
the normotensive children of hypertensive parents
have a significantly raised renal plasma flow and a
tendency towards a lower plasma renin activity is
also compatible with these children having a slightly
raised extracellular fluid volume. Plasma volumes,
however, are not increased.
Evidence that there is a rise in the concentration
of a circulating substance that causes the blood
pressure to rise is circumstantial, as it is in the rat.
Mizukoshi, Michelakis, et al [89, 90] have demon-
strated that the plasma of hypertensive man con-
tains a substance which increases the vascular reac-
tivity of rats to noradrenaline and angiotensin. It is
possible, therefore, that the presence of this circu-
lating substance is responsible for the increased
vascular reactivity of patients with essential hyper-
tension to noradrenaline and angiotensin [91-93].
Increased vascular reactivity has been found in the
normotensive children of hypertensive parents [92,
94], which strongly suggests that, as in the rat, the
increase in vascular reactivity is not due to second-
ary changes in the arterial wall produced by the rise
in pressure [51]. Finally, as in the rat, there is a for-
midable accumulation of evidence that in essential
hypertension there is a generalized impairment of
net sodium-potassium membrane transport—an ab-
normality that is compatible with an increase in
concentration of a circulating sodium-transport in-
hibitor. Tobian and Binion [95] first showed that the
intracellular concentration of sodium in the renal ar-
teries of hypertensive patients is raised. Sub-
sequently, abnormalities of sodium-potassium
transport have been repeatedly demonstrated in the
red cells [96—101], leukocytes [102, 103], lympho-
cytes [104], and in red cells studied with lithium
[105] of patients with essential hypertension. As in
the red cells of rats, the techniques that have been
used to study cell membrane sodium-potassium
transport in man vary widely, and the results are
therefore difficult to compare. There is agreement
that the intracellular sodium concentration is raised
and that there are demonstrable changes in sodium-
potassium fluxes. But some workers consider that
their findings are due to an increase in permeability;
and others, to a diminution in active transport.
Three groups have found also the same abnormal-
ities of membrane transport in the red cells of nor-
motensive relatives of hypertensive patients [98, 100,
101]. In addition, two other groups have reported
that the sodium-potassium transport abnormalities
they found in untreated hypertensive patients were
not present in the red cells and leukocytes of pa-
tients treated with diuretics [97, 103]. Postnov et al
[99] ascribed the changes in sodium-potassium
transport in the red cells to an increased per-
meability, for they obtained the same abnormalities
of calcium binding capacity of the red cell mem-
branes from hypertensive man as they did in the red
cells from the spontaneously hypertensive rat [60].
In view of the evidence described above that
demonstrates the many similarities shared by essen-
tial hypertension in man, stock colony rat hyper-
tension, and rats with either salt-sensitive or spon-
taneous hypertension, we would propose the fol-
lowing hypothesis (Fig. 1). Essential hypertension
in man is due to an inherited variability in the ability
of the kidney to eliminate sodium. This variability
becomes increasingly obvious the greater the so-
dium intake. The difficulty in eliminating sodium in-
creases the concentration of a circulating sodium-
transport inhibitor. This substance affects sodium
transport across cell membranes. In the kidney, it
adjusts urinary sodium excretion so that sodium
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Fig. 1. Hypothesis for hypertension.
balance is near that of normal subjects on the same
intake of sodium, thus making it difficult to demon-
strate an increase in extracellular fluid volume. In
the arteriole, it causes a rise in intracellular sodium
concentration, which in turn raises the intracellular
calcium concentration and thus increases vascular
reactivity. These changes induce a gradual rise in
arterial pressure. The rate and extent of the rise will
depend on the severity of the inherited defect in
eliminating sodium, and on the sodium intake.
The autoregulatory hypothesis of Ledingham
[106], the neurogenic hypothesis of Dickinson [107],
and the structural hypothesis of Folkow [51] to ex-
plain the development and maintenance of essential
hypertension in man, do not incorporate an ex-
planation for the widespread alterations in cell
membrane transport. There is a proposal that these
abnormalities are due to an inherited defect of the
cell membrane [96], which we would submit is not
compatible with the following observations: (1) that
plasma from hypertensive man can alter the vascu-
lar reactivity of the rat into which it is injected [90];
(2) that sodium-potassium transport defects in the
red cells and leukocytes are not present in hyper-
tensive patients treated with diuretics [97, 103], for
the direct action of diuretics on circulating cells, if
any, should be to make the abnormalities worse;
and (3) that incubation of leukocytes from normo-
tensive subjects in the plasma of patients with es-
sential hypertension reduces the total sodium effiux
rate constant and raises the intracellular sodium
concentration to the same levels as those found in
the white cells of patients with essential hyper-
tension [108]. This indicates that the plasma of pa-
tients with essential hypertension has an inhibitory
effect on the sodium transport of normal leuko-
cytes. It follows that the defect of sodium transport
observed in the white cells of hypertensive subjects
[102] is more probably due to this inhibitory effect
in the plasma rather than an inherited abnormality
of the cell membrane.
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